These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19057847)

  • 1. Seroprevalence of parvovirus B19 in fibromyalgia syndrome.
    Buyukkose M; Kozanoglu E; Basaran S; Bayramoglu O; Yarkin F
    Clin Rheumatol; 2009 Mar; 28(3):305-9. PubMed ID: 19057847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of indirect immunofluorescence (IIF) and ELISA techniques in the detection of parvovirus B19].
    González M; Hassanhi M; Rivera S; Bracho MP
    Invest Clin; 2000 Mar; 41(1):19-27. PubMed ID: 10758696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Established fibromyalgia syndrome and parvovirus B19 infection.
    Berg AM; Naides SJ; Simms RW
    J Rheumatol; 1993 Nov; 20(11):1941-3. PubMed ID: 8308782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of antibody to human parvovirus B19 in pregnant women in Kuwait.
    Maksheed M; Pacsa AS; Essa SS; Ahmed MA; Monem RA; Surkouh M
    Acta Trop; 1999 Oct; 73(3):225-9. PubMed ID: 10546839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo State, Nigeria.
    Abiodun I; Opaleye OO; Ojurongbe O; Fagbami AH
    J Infect Dev Ctries; 2013 Dec; 7(12):946-50. PubMed ID: 24334941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parvovirus B19 Seroprevalence in Women with Bad Obstetric History in Kirkuk.
    Alsamarai AM; Hassan HM; Alsamarai MA; Aljumaili ZK
    Antiinflamm Antiallergy Agents Med Chem; 2021; 20(4):359-366. PubMed ID: 34315400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of parvovirus B19 among pregnant women in Tripoli, Libya.
    Elnifro E; Nisha AK; Almabsoot M; Daeki A; Mujber N; Muscat J
    J Infect Dev Ctries; 2009 Apr; 3(3):218-20. PubMed ID: 19759477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of parvovirus B19 seroprevalence in various age groups in Central Anatolia Region, Turkey].
    Türk Dağı H; Ozdemir M; Baykan M; Baysal B
    Mikrobiyol Bul; 2010 Jul; 44(3):467-72. PubMed ID: 21063997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Seroprevalence of parvovirus B19 in patients with chronic idiopathic thrombocytopenic purpura].
    Uslu H; Kiki I; Ozbek A; Erdem F; Ayyildiz A
    Mikrobiyol Bul; 2007 Oct; 41(4):597-602. PubMed ID: 18173080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parvovirus B19 diagnosis in pregnant women--quantification of IgG antibody levels (IU/ml) with reference to the international parvovirus B19 standard serum.
    Searle K; Guilliard C; Enders G
    Infection; 1997; 25(1):32-4. PubMed ID: 9039535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of human parvovirus B19 in cancer patients using ELISA and real-time PCR.
    Zaki SA
    Indian J Med Microbiol; 2012; 30(4):407-10. PubMed ID: 23183464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The investigation of parvovirus B19 infection in patients with haematological disorders by using PCR and ELISA techniques.
    Us T; Ozune L; Kasifoglu N; Akgun Y
    Braz J Infect Dis; 2007 Jun; 11(3):327-30. PubMed ID: 17684634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and serological assessment of parvovirus B19 infections among sickle cell anemia patients.
    Obeid OE
    J Infect Dev Ctries; 2011 Jul; 5(7):535-9. PubMed ID: 21795822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
    Pfrepper KI; Enders M; Motz M
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):362-5. PubMed ID: 16316402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors.
    Zadsar M; Aghakhani A; Banifazl M; Kazemimanesh M; Tabatabaei Yazdi SM; Mamishi S; Bavand A; Sadat Larijani M; Ramezani A
    J Med Virol; 2018 Aug; 90(8):1318-1322. PubMed ID: 29663448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parvovirus B19 antibodies in immunocompromized children in Thailand.
    Suandork P; Theamboonlers A; Likitnukul S; Hirsch P; Poovorawan Y
    Asian Pac J Allergy Immunol; 2000 Sep; 18(3):161-4. PubMed ID: 11270472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parvovirus B19 antibodies and correlates of infection in pregnant women attending an antenatal clinic in central Nigeria.
    Emiasegen SE; Nimzing L; Adoga MP; Ohagenyi AY; Lekan R
    Mem Inst Oswaldo Cruz; 2011 Mar; 106(2):227-31. PubMed ID: 21537685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased seroprevalence of parvovirus B 19 IgG in complex regional pain syndrome is not associated with antiendothelial autoimmunity.
    Gross O; Tschernatsch M; Bräu ME; Hempelmann G; Birklein F; Kaps M; Madlener K; Blaes F
    Eur J Pain; 2007 Feb; 11(2):237-40. PubMed ID: 16545972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
    Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
    J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroepidemiology of human parvovirus B19 in Taiwan.
    Lin KH; You SL; Chen CJ; Wang CF; Yang CS; Yamazaki S
    J Med Virol; 1999 Feb; 57(2):169-73. PubMed ID: 9892403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.